On Tuesday, Opko Health Inc (NASDAQ: OPK) was -0.75% drop from the session before settling in for the closing price of $1.34. A 52-week range for OPK has been $1.21 – $2.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 32.04%. When this article was written, the company’s average yearly earnings per share was at -335.42%. With a float of $350.18 million, this company’s outstanding shares have now reached $671.61 million.
Considering the fact that the conglomerate employs 2997 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 32.12%, operating margin of -21.43%, and the pretax margin is -0.08%.
Opko Health Inc (OPK) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Opko Health Inc stocks. The insider ownership of Opko Health Inc is 55.84%, while institutional ownership is 31.97%. The most recent insider transaction that took place on Apr 10 ’25, was worth 169,712. In this transaction CEO & Chairman of this company bought 125,000 shares at a rate of $1.36, taking the stock ownership to the 214,001,448 shares. Before that another transaction happened on Apr 08 ’25, when Company’s CEO & Chairman bought 125,000 for $1.48, making the entire transaction worth $184,650. This insider now owns 213,876,448 shares in total.
Opko Health Inc (OPK) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -335.42% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.00% during the next five years compared to 32.04% growth over the previous five years of trading.
Opko Health Inc (NASDAQ: OPK) Trading Performance Indicators
You can see what Opko Health Inc (OPK) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.28. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.08, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.21 in one year’s time.
Technical Analysis of Opko Health Inc (OPK)
Compared to the last year’s volume of 4.01 million, its volume of 2.05 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 35.78%.
During the past 100 days, Opko Health Inc’s (OPK) raw stochastic average was set at 14.55%, which indicates a significant decrease from 53.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0396 in the past 14 days, which was lower than the 0.0631 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3234, while its 200-day Moving Average is $1.5044. Nevertheless, the first resistance level for the watch stands at $1.3533 in the near term. At $1.3767, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.3933. If the price goes on to break the first support level at $1.3133, it is likely to go to the next support level at $1.2967. Now, if the price goes above the second support level, the third support stands at $1.2733.
Opko Health Inc (NASDAQ: OPK) Key Stats
There are 793,053K outstanding shares of the company, which has a market capitalization of 1.05 billion. As of now, sales total 713,140 K while income totals -53,220 K. Its latest quarter income was 149,950 K while its last quarter net income were -67,610 K.
